ASHKAN HASHEMI-SABOUR: Open Payments
NPI 1417481615 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 25 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $172 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $141 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Merck Sharp & Dohme LLC | 3 | $79 |
| ViiV Healthcare Company | 2 | $48 |
| Paratek Pharmaceuticals, Inc. | 2 | $41 |
| Shionogi Inc | 2 | $31 |
| Mannkind Corporation | 1 | $25 |
| INOGEN, INC. | 1 | $23 |
| PFIZER INC. | 1 | $15 |
Products named: AIRSUPRA, DALVANCE, ZERBAXA, NUZYRA, CABENUVA, TEFLARO, Fetroja, AFREZZA.
Industry payments across NV — which companies pay providers there.
